Development and application of neonatal physiology‐based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment
Abstract Antimicrobial resistance increasingly complicates neonatal sepsis in a global context. Fosfomycin and amikacin are two agents being tested in an ongoing multicenter neonatal sepsis trial. Although neonatal pharmacokinetics (PKs) have been described for these drugs, the physiological variabi...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2024-03-01
|
| Collection: | CPT: Pharmacometrics & Systems Pharmacology |
| Accès en ligne: | https://doi.org/10.1002/psp4.13097 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|